Activation of the hTERT expression in squamous cell cervical carcinoma is not associated with gene amplification

Oncology Reports

Volumn 20, Issue 2, 2008, Pages 469-474

  Anedchenko, Ekaterina ^a   Oparina, Nina ^a   Dmitriev, Alexei ^a   Krasnov, George ^a   Pavlova, Larisa ^b   Alexandrova, Natalya ^b   Kisseljov, Fjodor ^b   Senchenko, Vera ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

hTERT DNA copy number; hTERT mRNA level; Quantitative real time PCR; Squamous cell cervical carcinoma; Telomerase

Indexed keywords

BETA ACTIN; BETA GLUCURONIDASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE ACTIVATION; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE NUMBER; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TUMOR DIFFERENTIATION; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; DNA, NEOPLASM; ENZYME ACTIVATION; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; RNA, MESSENGER; RNA, NEOPLASM; TELOMERASE; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 48749091078     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or_00000030     Document Type: Article

References (22)

1. Autexier C and Lue NF: The Structure and function of telomerase reverse transcriptase. Annu Rev Biochem 75: 493-517, 2006.
2. Bettendorf O, Heine B, Kneif S, Eltze E, Semjonow A, Herbst H, Stein H, Bocker W and Poremba C: Expression-patterns of the RNA component (hTR) and the catalytic subunit (hTERT) of human telomerase in non-neoplastic prostate tissue, prostatic intraepithelial neoplasia and prostate cancer. Prostate 55: 99-104, 2003.
3. Horikawa I and Barrett JC: Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 24: 1167-1176, 2003.
4. Zhang A, Zheng C, Hou V, Lindvall C, Wallin K, Angstrom T, Yang X, Hellstrom A, Blennow E, Bjorkholm E, Zetterberg A, Gruber A and Xu D: Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas. Genes Chromosomes Cancer 34: 269-275, 2002.
5. Zhang A, Zheng C, Lindvall C, Hou M, Ekedahl J, Lewensohn R, Yan Z, Yang X, Henrikson M, Blennow E, Nordenskjold V, Zetterberg A, Djorkholm M, Gruber A and Xu D: Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res 60: 6320-6325, 2000.
6. Oikonomou P, Mademitzis I, Messinis I and Tsezou A: Quantitative determination of human telomerase transcriptase messenger RNA expression in premalignant cervical lesions and correlation with human papillomavirus load. Human Pathol 7: 135-142, 2006.
7. Kisseljov FL, Kisseljova NP, Kobzeva VK, Gritsko TM, Semenova LA, Pavlova LS, Klaes R and von Knebel-Doeberitz M: State of human papilloma virus DNA in cervical carcinomas. Mol Biol 35: 399-404, 2001.
8. Anedchenko EA, Kisseljova NP, Dmitriev AA, Kisseljov FL, Zabarovsky ER and Senchenko VN: Tumor suppressor gene RBSP3 in cervical carcinoma: copy number and transcription level. Mol Biol 41: 77-85, 2007.
9. Manzeniuk OY, Malakho SG, Pekhov VM, Kosorukova IS and Poltaraus AB: Characterization of Russian universal kits for real-time PCR: application to molecular oncodiagnosis. Mol Biol 40: 305-311, 2006.
10. Glantz SA: Primer of Biostatistics. 4th edition. McGraw-Hill Inc., NY, 1994.
11. Tsezou A, Oikonomou P, Kollia P, Mademtzis I, Kostopoulou E, Messinis I and Vamvakopoulos N: The role of human telomerase catalytic subunit transcription in cervical dysplasias. Exp Biol Med 230: 263-270, 2005.
12. Skvortsov DA, Gasparian NM, Rubtsova MP, Zvereva ME, Fedorova MD, Pavlova LS, Bogdanov AA, Dontsova OA and Kisseljov FL: Telomerase as a potential marker for early diagnosing cervical carcinoma. Dokl Biochem Biophys 408: 158-160, 2006.
13. Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Ruutu M, Syrjanen S, Favalli C and Syrjanen K: Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer. Diagn Cytopathol 34: 739-748, 2006.
14. Atkinson SP, Hoare SF, Glasspool RM and Keith WN: Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res 65: 7585-7590, 2005.
15. Jiang WQ, Zhong ZH, Henson JD and Reddel RR: Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene 26: 4635-4647, 2007.
16. Widschwendter A, Muller HM, Hubalek MM, Wiedemair A, Fiegl H, Goebel G, Mueller-Holzner E, Marth C and Widschwendter M: Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer. Gynecol Oncol 93: 407-416, 2004.
17. Zinn RL, Pruitt K, Eguchi S, Baylin SB and Herman JG: hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res 67: 194-201, 2007.
18. Baege AC, Berger A, Schlegel R, Veldman T and Schlegel R: Cervical epithelial cells transduced with the papillomavirus E6/ E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity. Am J Pathol 160: 1251-1257, 2002.
19. Kailash U. Soundararajan CC, Lakshmy R, Arora R, Vivekanandhan S and Das BC: Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer 95: 1250-1257, 2006.
20. Fan X, Wang Y, Kratz J, Barat D, Robitaille Y, Moghrabi A, Perlman E, Dang C, Burger P and Eberhart C: hTERT gene amplification and increased transcription in central nervous system embryonal tumors. Am J Pathol 162: 1763-1769, 2003.
21. Racek T, Mise N, Li Z, Stoll A and Putzer BM: C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter. J Biol Chem 280: 40402-40405, 2005.
22. Ulaner GA, Hu JF, Vu TH, Oruganti H, Giudice LC and Hoffman AR: Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int J Cancer 85: 330-335, 2000.